Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
89912543 | 8991254 | 3 | F | 20130417 | 20160803 | 20121231 | 20160811 | EXP | CA-ROCHE-1169182 | ROCHE | 58.05 | YR | F | Y | 138.47000 | KG | 20160811 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
89912543 | 8991254 | 1 | PS | Omalizumab | OMALIZUMAB | 1 | Subcutaneous | 300 MG, EVERY 3 WEEKS | U | U | S00777,S0077,S0077A,S0072B | 103976 | 300 | MG | SOLUTION FOR INJECTION | QOW | |||
89912543 | 8991254 | 2 | SS | Omalizumab | OMALIZUMAB | 1 | Subcutaneous | 300 MG, BIW | U | U | S00777,S0077,S0077A,S0072B | 103976 | 300 | MG | SOLUTION FOR INJECTION | QOW | |||
89912543 | 8991254 | 3 | SS | Omalizumab | OMALIZUMAB | 1 | Subcutaneous | 300 MG, BIW | U | U | S00777,S0077,S0077A,S0072B | 103976 | 300 | MG | SOLUTION FOR INJECTION | QOW | |||
89912543 | 8991254 | 4 | SS | Omalizumab | OMALIZUMAB | 1 | Subcutaneous | UNK | U | U | S00777,S0077,S0077A,S0072B | 103976 | 300 | MG | SOLUTION FOR INJECTION | BID | |||
89912543 | 8991254 | 5 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | U | 0 | ||||||||||
89912543 | 8991254 | 6 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Unknown | U | 0 | ||||||||||
89912543 | 8991254 | 7 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | U | 0 | ||||||||||
89912543 | 8991254 | 8 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
89912543 | 8991254 | 1 | Asthma |
89912543 | 8991254 | 5 | Product used for unknown indication |
89912543 | 8991254 | 6 | Product used for unknown indication |
89912543 | 8991254 | 7 | Product used for unknown indication |
89912543 | 8991254 | 8 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
89912543 | 8991254 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
89912543 | 8991254 | Arterial occlusive disease | |
89912543 | 8991254 | Asthma | |
89912543 | 8991254 | Back pain | |
89912543 | 8991254 | Blood pressure decreased | |
89912543 | 8991254 | Bronchitis | |
89912543 | 8991254 | Cellulitis | |
89912543 | 8991254 | Chest discomfort | |
89912543 | 8991254 | Constipation | |
89912543 | 8991254 | Cough | |
89912543 | 8991254 | Dysphonia | |
89912543 | 8991254 | Fibromyalgia | |
89912543 | 8991254 | Heart rate increased | |
89912543 | 8991254 | Hypersensitivity | |
89912543 | 8991254 | Lower respiratory tract infection | |
89912543 | 8991254 | Nasopharyngitis | |
89912543 | 8991254 | Sinus congestion | |
89912543 | 8991254 | Sleep apnoea syndrome | |
89912543 | 8991254 | Suffocation feeling | |
89912543 | 8991254 | Throat irritation | |
89912543 | 8991254 | Tooth abscess | |
89912543 | 8991254 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
89912543 | 8991254 | 1 | 20080129 | 0 | ||
89912543 | 8991254 | 2 | 20090817 | 0 | ||
89912543 | 8991254 | 3 | 20090914 | 0 | ||
89912543 | 8991254 | 4 | 20080929 | 0 |